{"id":"BILL-QLD-3265","name":"Health Legislation Amendment Bill (No. 3) 2025","slug":"health-legislation-amendment-bill-no-3-2025","collection":"bill","jurisdiction":"qld","status":"in_force","isInForce":true,"actNumber":null,"makingDate":"2025-01-01","administeringDepartment":null,"currentVersion":{"id":446099,"registerId":"BILL-QLD-3265:current","compilationNumber":null,"startDate":"2025-01-01","status":"in_force","reasons":null,"registeredAt":"2026-05-06T12:45:16.593Z"},"sections":[{"sectionNumber":"retrieval-0001","sectionType":"document_chunk","heading":"Document excerpt 1","content":"# Health Legislation Amendment Bill (No. 3) 2025\n\nQueensland\nHealth Legislation\nAmendment Bill (No. 3) 2025\n\nQueensland\nHealth Legislation Amendment Bill (No. 3)\n2025\nContents\nPage\nPart 1 Preliminary\n1 Short title . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8\n2 Commencement . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8\nPart 2 Amendment of Assisted Reproductive Technology Act 2024\n3 Act amended . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 9\n4 Amendment of s 15 (Counselling services for persons provided with ART\nservices) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 9\n5 Insertion of new s 16A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 10\n16A Consent required for obtaining, or attempting to obtain,\ngamete . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 10\n6 Amendment of s 18 (Consent of gamete provider in case of donated\ngametes or donated embryos) . . . . . . . . . . . . . . . . . . . . . . . . . . 10\n7 Amendment of s 25 (Limit on number of donor-related Australian\nfamilies) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 11\n8 Amendment of s 27 (Time limit on use of donated gametes or embryos\nand their disposal) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 11\n9 Amendment of s 33 (Information to be collected about gamete providers)\n. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 12\n10 Amendment of s 34 (Transfer between ART providers of information\nabout gametes or embryos) . . . . . . . . . . . . . . . . . . . . . . . . . . . . 13\n11 Amendment of s 35 (Information to be collected about persons who\nundergo ART procedures) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 14\n12 Amendment of s 36 (Keeping of records) . . . . . . . . . . . . . . . . . . 14\n13 Amendment of s 37 (Destruction of records prohibited) . . . . . . . 15\n14 Insertion of new pt 2, div 8 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 15\nDivision 8 Chief executive’s approval to use particular gametes or\nembryos\n39A Purpose of division . . . . . . . . . . . . . . . . . . . . . . . . . . 16\n\nContents\nHealth Legislation Amendment Bill (No. 3) 2025\nPage 2\nAuthorised by the Parliamentary Counsel\n39B Chief executive may approve use of particular donated\ngamete or donated embryo—ss 25 and 27 . . . . . . . . 16\n39C Chief executive may approve use of other particular gamete\nor embryo—s 33 . . . . . . . . . . . . . . . . . . . . . . . . . . . . 17\n15 Amendment of s 40 (Definitions for part) . . . . . . . . . . . . . . . . . . . 18\n16 Amendment of s 41 (Information relating to donor-conceived persons to\nwhich part applies) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 19\n17 Amendment of s 44 (Relevant information to be included in register) 19\n18 Amendment of s 45 (Mandatory provision of information by ART\nproviders) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 20\n19 Amendment of s 46 (Mandatory provision of historical information) 20\n20 Amendment of s 47 (Voluntary provision of information by parties to\nprivate donor conception procedures) . . . . . . . . . . . . . . . . . . . . . 20\n21 Insertion of new s 56A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 20\n56A Meaning of accreditation standard . . . . . . . . . . . . . . 20\n22 Amendment of s 57 (Application for licence) . . . . . . . . . . . . . . . . 21\n23 Amendment of s 61 (Chief executive to be notified of certain events) 21\n24 Amendment of s 64 (Cancellation or suspension of licence) . . . 22\n25 Amendment of s 65 (Public register of licensed providers) . . . . . 22\n26 Amendment of s 111 (Power to require information) . . . . . . . . . . 22\n27 Amendment of s 112 (Offence to contravene information requirement)\n. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 23\n28 Amendment of s 119 (Definitions for part) . . . . . . . . . . . . . . . . . . 23\n29 Replacement of s 120 (Review process must start with internal review)\n. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 24\n120 Review process for reviewable decisions . . . . . . . . . 24\n30 Amendment of s 123 (Internal review) . . . . . . . . . . . . . . . . . . . . 24\n31 Amendment of s 124 (QCAT may stay operation of reviewable decision)\n. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 25\n32 Replacement of s 125 (Applying for QCAT external review) . . . . 26\n125 Applying for QCAT external review . . . . . . . . . . . . . . 26\n33 Amendment of s 138 (Executive officer may be taken to have committed\noffence against deemed executive liability provision) . . . . . . . . . 26\n34 Insertion of new pt 9, div 1, hdg . . . . . . . . . . . . . . . . . . . . . . . . . 26\n35 Insertion of new pt 9, div 2, hdg . . . . . . . . . . . . . . . . . . . . . . . . . 27\n36 Insertion of new pt 9, div 2, sdiv 1 . . . . . . . . . . . . . . . . . . . . . . . . 27\nSubdivision 1 Preliminary\n144B Definitions for division . . . . . . . . . . . . . . . . . . . . . . . . 27\n\nContents\nHealth Legislation Amendment Bill (No. 3) 2025\nPage 3\nAuthorised by the Parliamentary Counsel\n144C Particular references to spouses . . . . . . . . . . . . . . . . 28\n37 Insertion of new pt 9, div 2, sdiv 2, hdg . . . . . . . . . . . . . . . . . . . . 28\n38 Amendment of s 145 (Licensing of existing ART providers) . . . . 28\n39 Insertion of new s 145A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 29\n145A Licensed providers’ notification of particular events that\nhappened before commencement—new s 61 . . . . . . 29\n40 Insertion of new pt 9, div 2, sdiv 3 . . . . . . . . . . . . . . . . . . . . . . . . 29\nSubdivision 3 Provisions for general operation of part 2\n145B Donor-related Australian families—new s 25 . . . . . . 30\n145C Time limits on use of existing donated gametes and\nembryos—new s 27 . . . . . . . . . . . . . . . . . . . . . . . . . . 30\n145D Record-keeping—s 36 . . . . . . . . . . . . . . . . . . . . . . . . 30\n145E Disclosure of health information—s 38 . . . . . . . . . . . 31\n41 Insertion of new pt 9, div 2, sdiv 4, hdg . . . . . . . . . . . . . . . . . . . . 31\n42 Replacement of ss 146–149 . . . . . . . . . . . . . . . . . . . . . . . . . . . . 31\n146 Donated gametes previously allocated to person for ART\nprocedures . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 31\n147 Donated embryo previously allocated to a person for ART\nprocedures . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 33\n148 Embryo created with donated gamete not yet used for ART\nprocedure . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 34\n149 Use of particular gametes obtained before 19 September\n2024—collection of information . . . . . . . . . . . . . . . . . 35\n43 Renumbering and relocation of s 150 (Time within which information\nabout pregnancies and births to be collected by ART providers) 36\n44 Insertion of new pt 9, div 2, sdiv 5, hdg . . . . . . . . . . . . . . . . . . . . 36\n45 Insertion of new ss 152 and 153 . . . . . . . . . . . . . . . . . . . . . . . . . 37\n152 Relationship of division with s 144 . . . . . . . . . . . . . . 37\n153 Transitional regulation-making power . . . . . . . . . . . . 37\n46 Amendment of sch 1 (Dictionary) . . . . . . . . . . . . . . . . . . . . . . . . 37\nPart 3 Amendment of Health and Wellbeing Queensland Act 2019\n47 Act amended . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 38\n48 Amendment of s 23 (Vacancy in office) . . . . . . . . . . . . . . . . . . . . 38\n49 Amendment of s 24 (Acting board member) . . . . . . . . . . . . . . . . 39\n50 Amendment of s 37 (Vacancy in office) . . . . . . . . . . . . . . . . . . . . 39\n51 Amendment of s 38 (Acting chief executive officer) . . . . . . . . . . 39\n52 Insertion of new pt 7 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 39\nPart 7 Transitional provisions for Health Legislation\n\nContents\nHealth Legislation Amendment Bill (No. 3) 2025\nPage 4\nAuthorised by the Parliamentary Counsel\nAmendment Act (No. 3) 2025\n52 Vacancy in office of board member . . . . . . . . . . . . . . 40\n53 Vacancy in office of chief executive officer . . . . . . . . 40\nPart 4 Amendment of Health Legislation Amendment Act 2025\n53 Act amended . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 40\n54 Replacement of s 7 (Amendment of s 28 (Removal from office of board\nmembers)) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 40\n7 Amendment of s 25A (Disqualification as board member) 40\nPart 5 Amendment of Hospital and Health Boards Act 2011\n55 Act amended . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 41\n56 Insertion of new s 25A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 41\n25A Disqualification as board member . . . . . . . . . . . . . . . 41\n57 Amendment of s 27 (Vacation of office of board member) . . . . . 41\n58 Amendment of s 27A (Suspension from office of Hospital and Health\nBoard members) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 42\n59 Omission of s 28 (Removal from office of board members) . . . . 42\n60 Insertion of new pt 13, div 9 . . . . . . . . . . . . . . . . . . . . . . . . . . . . 42\nDivision 9 Transitional provision for Health Legislation\nAmendment Act (No. 3) 2025\n332 Vacancy in office of board member . . . . . . . . . . . . . . 43\n61 Amendment of sch 2 (Dictionary) . . . . . . . . . . . . . . . . . . . . . . . . 43\nPart 6 Amendment of Hospital Foundations Act 2018\n62 Act amended . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 43\n63 Amendment of s 33 (Disqualification from becoming member) . . 43\n64 Omission of s 34 (Removal from office) . . . . . . . . . . . . . . . . . . . 44\n65 Amendment of s 35 (Vacancy in office) . . . . . . . . . . . . . . . . . . . . 44\n66 Insertion of new s 35A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 44\n35A Acting board member . . . . . . . . . . . . . . . . . . . . . . . . 44\n67 Amendment of s 36 (Criminal history report) . . . . . . . . . . . . . . . . 45\n68 Insertion of new pt 9, div 3 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 45\nDivision 3 Transitional provision for Health Legislation\nAmendment Act (No. 3) 2025\n93 Vacancy in office of board member . . . . . . . . . . . . . . 45\nPart 7 Amendment of Pharmacy Business Ownership Act 2024\n69 Act amended . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 46\n70 Replacement of s 156 (Vacancy in office) . . . . . . . . . . . . . . . . . . 46\n156 Vacancy in office . . . . . . . . . . . . . . . . . . . . . . . . . . . . 46\n\nContents\nHealth Legislation Amendment Bill (No. 3) 2025\nPage 5\nAuthorised by the Parliamentary Counsel\n156A Acting council member . . . . . . . . . . . . . . . . . . . . . . . 46\n71 Amendment of s 171 (Vacancy in office) . . . . . . . . . . . . . . . . . . . 47\n72 Amendment of s 172 (Acting chief executive officer) . . . . . . . . . 47\n73 Replacement of pt 14, hdg (Transitional provisions) . . . . . . . . . . 47\n74 Relocation and renumbering of pt 15, div 1 (Repeal) . . . . . . . . . 48\n75 Replacement of pt 15 (Repeal and amendments of legislation) . 48\nPart 15 Transitional provisions for Health Legislation\nAmendment Act (No. 3) 2025\n235 Vacancy in office of council member . . . . . . . . . . . . . 48\n236 Vacancy in office of chief executive officer . . . . . . . . 48\nPart 8 Amendment of Private Health Facilities Act 1999\n76 Act amended . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 49\n77 Amendment of s 48 (Conditions of licence) . . . . . . . . . . . . . . . . . 49\n78 Amendment of s 50 (Term of licences) . . . . . . . . . . . . . . . . . . . . 49\n79 Amendment of s 144 (Submission of reports) . . . . . . . . . . . . . . . 49\n80 Amendment of s 147 (Confidentiality of information) . . . . . . . . . 50\nPart 9 Amendment of Transplantation and Anatomy Act 1979\n81 Act amended . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 50\n82 Amendment of s 4 (Interpretation) . . . . . . . . . . . . . . . . . . . . . . . . 50\n83 Replacement of pt 2, div 4, hdg (Blood transfusions) . . . . . . . . . 51\n84 Amendment of s 17 (Consents by adults to removal of blood) . . 51\n85 Amendment of s 18 (Consents to removal of blood from children) 51\n86 Insertion of new s 18A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 52\n18A Consents to removal of blood from children or adults with\nimpaired capacity for determining tissue donation viability 52\n87 Replacement of s 19 (Consent to be sufficient authority for removal of\nblood) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 52\n19 Consent to be sufficient authority for removal of blood 52\n88 Insertion of new pt 3A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 52\nPart 3A Ante-mortem interventions\n25A What is an ante-mortem intervention . . . . . . . . . . . . 53\n25B Authority for ante-mortem intervention—adult with capacity\n. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 53\n25C Authority for ante-mortem intervention—child or adult with\nimpaired capacity . . . . . . . . . . . . . . . . . . . . . . . . . . . 53\nPart 10 Other amendments\n89 Legislation amended . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 55\n\nContents\nHealth Legislation Amendment Bill (No. 3) 2025\nPage 6\nAuthorised by the Parliamentary Counsel\nSchedule 1 Other amendments . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 56\nPublic Health Act 2005 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 56\nTransplantation and Anatomy Act 1979 . . . . . . . . . . . . . . . . . . . 57\n\n2025\nA Bill\nfor\nAn Act to amend the Assisted Reproductive Technology Act\n2024, the Health and Wellbeing Queensland Act 2019, the Health\nLegislation Amendment Act 2025, the Hospital and Health\nBoards Act 2011, the Hospital Foundations Act 2018, the\nPharmacy Business Ownership Act 2024, the Private Health\nFacilities Act 1999, the Public Health Act 2005 and the\nTransplantation and Anatomy Act 1979 for particular purposes\n\n[s 1]\nHealth Legislation Amendment Bill (No. 3) 2025\nPart 1 Preliminary\nPage 8\nAuthorised by the Parliamentary Counsel\nThe Parliament of Queensland enacts—\nPart 1 Preliminary\n1 Short title\nThis Act may be cited as the Health Legislation Amendment\nAct (No. 3) 2025.\n2 Commencement\n(1) The following sections commence immediately after the\ncommencement of the Assisted Reproductive Technology Act\n2024, section 12—\n(a) sections 4 to 14;\n(b) sections 21 to 25;\n(c) sections 28 to 32;\n(d) sections 34 to 45;\n(e) section 46(1) and (2).\n(2) Sections 15(2) and 16 to 20 commence immediately after the\ncommencement of the Assisted Reproductive Technology Act\n2024, section 42.\n(3) Sections 77 and 78 commence on a day to be fixed by\nproclamation.\n1\n2\nClause 3\n4\n5\nClause 6\n7\n8\n9\n10\n11\n12\n13\n14\n15\n16\n17\n18\n19\n\n[s 3]\nHealth Legislation Amendment Bill (No. 3) 2025\nPart 2 Amendment of Assisted Reproductive Technology Act 2024\nPage 9\nAuthorised by the Parliamentary Counsel\nPart 2 Amendment of Assisted\nReproductive Technology Act\n2024\n3 Act amended\nThis part amends the Assisted Reproductive Technology Act\n2024.\n4 Amendment of s 15 (Counselling services for persons\nprovided with ART services)\n(1) Section 15(2)(a), ‘and to any spouse of that person’—\nomit.\n(2) Section 15(2), after paragraph (a)—\ninsert—\n(aa) to a spouse of the person, other than a\nspouse from whom the person is separated\nand is living separately and apart; and\n(3) Section 15(2)(aa) and (b)—\nrenumber as section 15(2)(b) and (c).\n(4) Section 15(3)—\nomit, insert—\n(3) An ART provider must make counselling services\navailable under this section to—\n(a) a person who proposes to undergo an ART\nprocedure that does not use donated gametes\nor a donated embryo; and\n(b) a spouse of the person, other than a spouse\nfrom whom the person is separated and is\nliving separately and apart.\nMaximum penalty—25 penalty units.\n1\n2\n3\nClause 4\n5\n6\nClause 7\n8\n9\n10\n11\n12\n13\n14\n15\n16\n17\n18\n19\n20\n21\n22\n23\n24\n25\n26\n27\n28","sortOrder":0},{"sectionNumber":"retrieval-0002","sectionType":"document_chunk","heading":"Document excerpt 2","content":"[s 5]\nHealth Legislation Amendment Bill (No. 3) 2025\nPart 2 Amendment of Assisted Reproductive Technology Act 2024\nPage 10\nAuthorised by the Parliamentary Counsel\n5 Insertion of new s 16A\nAfter section 16—\ninsert—\n16A Consent required for obtaining, or attempting\nto obtain, gamete\n(1) The consent of a gamete provider is required for\nobtaining, or attempting to obtain, a gamete from\nthe gamete provider for use in an ART procedure\nor for storage for use in an ART procedure.\n(2) The consent of a gamete provider is not required\nfor anything authorised under division 5.\n(3) The consent of a child includes the consent of a\nparent of the child or a person with parental\nresponsibility for the child.\n(4) A reference in this section to a gamete provider\nincludes, in relation to an attempt to obtain a\ngamete, a reference to the individual who would\nhave been the gamete provider had the attempt\nbeen successful.\n6 Amendment of s 18 (Consent of gamete provider in case\nof donated gametes or donated embryos)\n(1) Section 18(2)(b), from ‘for which’—\nomit, insert—\nduring which the donated gametes or donated\nembryos may be used in an ART procedure; and\n(2) Section 18—\ninsert—\n(3A) Subsection (1) does not apply to the extent a\ndonated gamete or donated embryo is used in an\nART procedure under an approval of the chief\nexecutive given, for the purpose of section 25(2)\nor 27(1), under section 39B.\nClause 1\n2\n3\n4\n5\n6\n7\n8\n9\n10\n11\n12\n13\n14\n15\n16\n17\n18\n19\nClause 20\n21\n22\n23\n24\n25\n26\n27\n28\n29\n30\n31\n32\n\n[s 7]\nHealth Legislation Amendment Bill (No. 3) 2025\nPart 2 Amendment of Assisted Reproductive Technology Act 2024\nPage 11\nAuthorised by the Parliamentary Counsel\n(3) Section 18(3A) and (4)—\nrenumber as section 18(4) and (5).\n7 Amendment of s 25 (Limit on number of donor-related\nAustralian families)\n(1) Section 25—\ninsert—\n(1A) Subsection (1) does not apply if the ART provider\nhas the approval of the chief executive given, for\nthe purpose of this subsection, under section 39B\nto use the donated gamete or donated embryo in\nthe ART procedure.\n(2) Section 25(1A) to (6)—\nrenumber as section 25(2) to (7).\n8 Amendment of s 27 (Time limit on use of donated\ngametes or embryos and their disposal)\n(1) Section 27(1), ‘written approval of the chief executive’—\nomit, insert—\napproval of the chief executive given, for the\npurpose of this subsection, under section 39B\n(2) Section 27(2) and (3)—\nomit, insert—\n(2) The ART provider must dispose of the donated\ngamete or donated embryo, within the period\nmentioned in subsection (3), if—\n(a) the chief executive has decided under\nsection 39B(2) to refuse to approve the use\nof the donated gamete or donated embryo in\nthe ART procedure (the refusal decision);\nand\n(b) either—\n1\n2\nClause 3\n4\n5\n6\n7\n8\n9\n10\n11\n12\n13\nClause 14\n15\n16\n17\n18\n19\n20\n21\n22\n23\n24\n25\n26\n27\n28\n29\n30\n\n[s 9]\nHealth Legislation Amendment Bill (No. 3) 2025\nPart 2 Amendment of Assisted Reproductive Technology Act 2024\nPage 12\nAuthorised by the Parliamentary Counsel\n(i) the period for applying for internal\nreview of the refusal decision under\nsection 122 has ended and no\napplication for internal review has been\nmade; or\n(ii) an application for internal review of the\nrefusal decision has been made under\nsection 122 and the chief executive has\ndecided under section 123 to confirm\nthe refusal decision.\nMaximum penalty—100 penalty units.\n(3) For subsection (2), the period within which the\nART provider must dispose of the donated gamete\nor donated embryo is as soon as practicable after\nthe end of the period of 90 days starting on—\n(a) if subsection (2)(b)(i) applies—the day the\nART provider is given an information notice\nfor the refusal decision under section\n39B(3); or\n(b) if subsection (2)(b)(ii) applies—the day the\nART provider is given a notice under section\n123(1)(c)(i) of the chief executive’s decision\non the internal review of the refusal\ndecision.\n9 Amendment of s 33 (Information to be collected about\ngamete providers)\n(1) Section 33(1)(a)(ii), from ‘residential’ to ‘email address’—\nomit, insert—\ncontact information\n(2) Section 33(3)—\nomit.\n(3) Section 33(5), from ‘unless’ to ‘under’—\nomit, insert—\n1\n2\n3\n4\n5\n6\n7\n8\n9\n10\n11\n12\n13\n14\n15\n16\n17\n18\n19\n20\n21\n22\n23\n24\nClause 25\n26\n27\n28\n29\n30\n31\n32\n33\n\n[s 10]\nHealth Legislation Amendment Bill (No. 3) 2025\nPart 2 Amendment of Assisted Reproductive Technology Act 2024\nPage 13\nAuthorised by the Parliamentary Counsel\nfor an ART procedure unless the provider has\ncollected the information mentioned in\n(4) Section 33—\ninsert—\n(6) Subsection (4) does not apply if the ART provider\nhas the approval of the chief executive given\nunder section 39C to use the gamete or embryo for\nthe ART procedure.\n(7) This section is not limited by, and does not limit,\nsection 34.\nNote—\nSee section 149 for the application of this section in\nrelation to gametes obtained before 19 September 2024.\n(5) Section 33(4) to (7)—\nrenumber as section 33(3) to (6).\n10 Amendment of s 34 (Transfer between ART providers of\ninformation about gametes or embryos)\n(1) Section 34(2)(a) and (b), ‘consents and other information’—\nomit, insert—\ninformation mentioned in subsection (3)\n(2) Section 34—\ninsert—\n(3) For subsection (2)(a) and (b), the information is—\n(a) the information mentioned in section 33(1)\nin relation to the gametes or gametes used to\ncreate the embryos; and\n(b) any other consents or information in relation\nto the gametes or embryos.\n1\n2\n3\n4\n5\n6\n7\n8\n9\n10\n11\n12\n13\n14\n15\nClause 16\n17\n18\n19\n20\n21\n22\n23\n24\n25\n26\n27\n28\n\n[s 11]\nHealth Legislation Amendment Bill (No. 3) 2025\nPart 2 Amendment of Assisted Reproductive Technology Act 2024\nPage 14\nAuthorised by the Parliamentary Counsel\n11 Amendment of s 35 (Information to be collected about\npersons who undergo ART procedures)\n(1) Section 35(1)(b), from ‘residential address’ to ‘email\naddress’—\nomit, insert—\ncontact information\n(2) Section 35(1)(d), from ‘any’—\nomit, insert—\na spouse of the person at the time of the\nprocedure, other than a spouse from whom, at that\ntime, the person is separated and is living\nseparately and apart.\n12 Amendment of s 36 (Keeping of records)\n(1) Section 36—\ninsert—\n(2A) An ART provider must keep a record of—\n(a) each consent of a person under section 16A\nfor attempting to obtain a gamete from the\nperson; and\n(b) a notice given to the ART provider by a\ngamete provider under section 20(2)\nmodifying or withdrawing a consent of the\ngamete provider under division 3.\n(2) Section 36(3)—\ninsert—\n(c) each consent of a person under division 3\nundergoing the ART procedures mentioned\nin that division.\n(3) Section 36(4)(b), from ‘name’ to ‘email address’—\nomit, insert—\nClause 1\n2\n3\n4\n5\n6\n7\n8\n9\n10\n11\n12\nClause 13\n14\n15\n16\n17\n18\n19\n20\n21\n22\n23\n24\n25\n26\n27\n28\n29\n30\n\n[s 13]\nHealth Legislation Amendment Bill (No. 3) 2025\nPart 2 Amendment of Assisted Reproductive Technology Act 2024\nPage 15\nAuthorised by the Parliamentary Counsel\nname and contact information\n(4) Section 36—\ninsert—\n(7) A reference in this section to an ART provider\nincludes a reference to a person who was an ART\nprovider.\n(5) Section 36(2A) to (7)—\nrenumber as section 36(3) to (8).\n13 Amendment of s 37 (Destruction of records prohibited)\n(1) Section 37(2), from ‘that’ to ‘authorises’—\nomit, insert—\nfor which the chief executive gives approval\n(2) Section 37(3), ‘authorise’—\nomit, insert—\ngive approval for\n(3) Section 37—\ninsert—\n(4) If the chief executive decides to refuse to approve\nan application for approval to destroy a record\nunder subsection (3), the chief executive must, as\nsoon as practicable after the decision is made,\ngive the applicant an information notice for the\ndecision.\n(5) A reference in this section to an ART provider\nincludes a reference to a person who was an ART\nprovider.\n14 Insertion of new pt 2, div 8\nPart 2—\n1\n2\n3\n4\n5\n6\n7\n8\nClause 9\n10\n11\n12\n13\n14\n15\n16\n17\n18\n19\n20\n21\n22\n23\n24\n25\n26\nClause 27\n28\n\n[s 14]\nHealth Legislation Amendment Bill (No. 3) 2025\nPart 2 Amendment of Assisted Reproductive Technology Act 2024\nPage 16\nAuthorised by the Parliamentary Counsel\ninsert—\nDivision 8 Chief executive’s approval\nto use particular gametes\nor embryos\n39A Purpose of division\nThe purpose of this division is to enable the chief\nexecutive to give an ART provider approval to\nuse a gamete or embryo in an ART procedure\neven though—\n(a) for a donated gamete or donated embryo—\n(i) the use of the donated gamete or\ndonated embryo would result in more\nthan 10 donor-related Australian\nfamilies; or\n(ii) the donated gamete, or a gamete used\nto create the donated embryo, was\nobtained from the gamete provider\nmore than 15 years before the ART\nprocedure; or\n(b) for any gamete or embryo—the ART\nprovider has not collected the information\nmentioned in section 33(1) in relation to the\ngamete or a gamete used to create the\nembryo.\n39B Chief executive may approve use of particular\ndonated gamete or donated embryo—ss 25\nand 27\n(1) This section applies for the purposes of section\n25(2) or 27(1).\n(2) The chief executive may, on application by an\nART provider, approve the use of a donated\ngamete or donated embryo in an ART procedure\n1\n2\n3\n4\n5\n6\n7\n8\n9\n10\n11\n12\n13\n14\n15\n16\n17\n18\n19\n20\n21\n22\n23\n24\n25\n26\n27\n28\n29\n30\n31\n32\n\n[s 14]\nHealth Legislation Amendment Bill (No. 3) 2025\nPart 2 Amendment of Assisted Reproductive Technology Act 2024\nPage 17\nAuthorised by the Parliamentary Counsel\nif the chief executive is satisfied—\n(a) either—\n(i) the gamete provider, or the gamete\nprovider from whom a gamete used to\ncreate the embryo was obtained, has\nconsented to the making of the\napplication by the ART provider; or\n(ii) the ART provider has been unable to\ncontact the gamete provider mentioned\nin subparagraph (i) despite taking\nreasonable steps to do so; and\n(b) there are reasonable grounds for using the\ndonated gamete or donated embryo in the\nART procedure, having regard to—\n(i) the terms of the consent given by the\ngamete provider for the use of the\ngamete, to the extent the consent\nrelates to the provision mentioned in\nsubsection (1) that is the subject of the\napplication; and\n(ii) whether, in the circumstances, the\nconsequences of giving, or refusing to\ngive, the approval would be unfairly\nharsh for any person.\n(3) If the chief executive decides to refuse to approve\nan application under subsection (2), the chief\nexecutive must, as soon as practicable after the\ndecision is made, give the applicant an\ninformation notice for the decision.\n39C Chief executive may approve use of other\nparticular gamete or embryo—s 33\n(1) This section applies for the purposes of section\n33(5).\n(2) The chief executive may, on application by an\n1\n2\n3\n4\n5\n6\n7\n8\n9\n10\n11\n12\n13\n14\n15\n16\n17\n18\n19\n20\n21\n22\n23\n24\n25\n26\n27\n28\n29\n30\n31\n32\n33\n34\n\n[s 15]\nHealth Legislation Amendment Bill (No. 3) 2025\nPart 2 Amendment of Assisted Reproductive Technology Act 2024\nPage 18\nAuthorised by the Parliamentary Counsel\nART provider, approve the use of a gamete or\nembryo in an ART procedure if the chief\nexecutive is satisfied—\n(a) the ART provider has taken reasonable steps\nto collect the information mentioned in\nsection 33(1) in relation to the gamete or a\ngamete used to create the embryo; and\n(b) there are reasonable grounds for using the\ngamete or embryo, having regard to—\n(i) the information the ART provider has\ncollected; and\n(ii) whether, in the circumstances, the\nconsequences of giving, or refusing to\ngive, the approval would be unfairly\nharsh for any person.\n(3) If the chief executive decides to approve an\napplication under subsection (2), the applicant\nand any other ART provider to whom the gamete\nor embryo is supplied—\n(a) may use the gamete or embryo despite\nsection 33(4); and\n(b) is taken to have complied with section 33(1)\nin relation to the gamete, or a gamete used\nto create the embryo.\n(4) If the chief executive decides to refuse to approve\nan application under subsection (2), the chief\nexecutive must, as soon as practicable after the\ndecision is made, give the applicant an\ninformation notice for the decision.\n15 Amendment of s 40 (Definitions for part)\n(1) Section 40, definition contact information—\nomit.\n(2) Section 40, definition relevant information, from ‘, relating’—\n1\n2\n3\n4\n5\n6\n7\n8\n9\n10\n11\n12\n13\n14\n15\n16\n17\n18\n19\n20\n21\n22\n23\n24\n25\n26\n27\n28\n29\nClause 30\n31\n32\n33\n\n[s 16]\nHealth Legislation Amendment Bill (No. 3) 2025\nPart 2 Amendment of Assisted Reproductive Technology Act 2024\nPage 19\nAuthorised by the Parliamentary Counsel\nomit, insert—\nsee section 44(1).\n16 Amendment of s 41 (Information relating to\ndonor-conceived persons to which part applies)\n(1) Section 41, heading, ‘relating to donor-conceived persons’—\nomit.\n(2) Section 41, from ‘relating’—\nomit, insert—\nin relation to a donor-conceived person.\n17 Amendment of s 44 (Relevant information to be included\nin register)\n(1) Section 44(1)—\nomit, insert—\n(1) The information mentioned in subsection (2) (the\nrelevant information), in relation to a\ndonor-conceived person, that is provided to the\nregistrar is the information that is to be included\nin the register.\n(2) Section 44(2)(i)—\nomit, insert—\n(i) the full name and date of birth of—\n(i) the person who gave birth to the\ndonor-conceived person as a result of\nthe procedure; and\n(ii) a spouse of the person at the time of the\nprocedure, other than a spouse from\nwhom, at that time, the person was\nseparated and was living separately and\napart;\n1\n2\nClause 3\n4\n5\n6\n7\n8\n9\nClause 10\n11\n12\n13\n14\n15\n16\n17\n18\n19\n20\n21\n22\n23\n24\n25\n26\n27\n28\n29\n\n[s 18]\nHealth Legislation Amendment Bill (No. 3) 2025\nPart 2 Amendment of Assisted Reproductive Technology Act 2024\nPage 20\nAuthorised by the Parliamentary Counsel\n18 Amendment of s 45 (Mandatory provision of information\nby ART providers)\nSection 45(1), ‘relating to the birth of a donor-conceived\nperson’—\nomit, insert—\nin relation to a donor-conceived person born\n19 Amendment of s 46 (Mandatory provision of historical\ninformation)\nSection 46(1)(a), ‘relates to the birth of a donor-conceived\nperson’—\nomit, insert—\nis information in relation to a donor-conceived\nperson born\n20 Amendment of s 47 (Voluntary provision of information\nby parties to private donor conception procedures)\nSection 47(1), ‘relating to the birth of a donor-conceived\nperson’—\nomit, insert—\nin relation to a donor-conceived person born\n21 Insertion of new s 56A\nBefore section 57—\ninsert—\n56A Meaning of accreditation standard\n(1) The accreditation standard is a document that—\n(a) provides for matters in relation to prescribed\naccreditation; and\n(b) is approved by regulation for this paragraph,\nwith or without modifications.\nClause 1\n2\n3\n4\n5\n6\nClause 7\n8\n9\n10\n11\n12\n13\nClause 14\n15\n16\n17\n18\n19\nClause 20\n21\n22\n23\n24\n25\n26\n27\n28\n\n[s 22]\nHealth Legislation Amendment Bill (No. 3) 2025\nPart 2 Amendment of Assisted Reproductive Technology Act 2024\nPage 21\nAuthorised by the Parliamentary Counsel\n(2) The Minister may recommend to the Governor in\nCouncil the making of a regulation under\nsubsection (1) only if the Minister is satisfied the\ndocument, including any modifications, provides\nfor the following matters—\n(a) persons who are personnel for sections\n57(2)(b)(iv), 61(1) and 65(2)(d);\n(b) events that are serious adverse events for\nsection 61.\n22 Amendment of s 57 (Application for licence)\n(1) Section 57(1)(a), ‘RTAC accreditation’—\nomit, insert—\nprescribed accreditation\n(2) Section 57(2)(b)(iv), from ‘any’ to ‘regulation’—\nomit, insert—\nthe name of each of the personnel, within the\nmeaning of the accreditation standard,\n23 Amendment of s 61 (Chief executive to be notified of\ncertain events)\n(1) Section 61(1), table, items 2 and 3, column 1, ‘RTAC\naccreditation’—\nomit, insert—\nprescribed accreditation\n(2) Section 61(1), table, item 8, column 1, from ‘any’ to\n‘regulation’—\nomit, insert—\nany of the personnel, within the meaning of the\naccreditation standard,\n1\n2\n3\n4\n5\n6\n7\n8\n9\nClause 10\n11\n12\n13\n14\n15\n16\n17\nClause 18\n19\n20\n21\n22\n23\n24\n25\n26\n27\n28\n\n[s 24]\nHealth Legislation Amendment Bill (No. 3) 2025\nPart 2 Amendment of Assisted Reproductive Technology Act 2024\nPage 22\nAuthorised by the Parliamentary Counsel\n(3) Section 61(3), definition serious adverse event, ‘prescribed by\nregulation’—\nomit, insert—\nidentified in the accreditation standard\n24 Amendment of s 64 (Cancellation or suspension of\nlicence)\nSection 64(1)(a), ‘RTAC accreditation’—\nomit, insert—\nprescribed accreditation\n25 Amendment of s 65 (Public register of licensed providers)\n(1) Section 65(2)(d), from ‘names’ to ‘regulation’—\nomit, insert—\nname of each of the personnel, within the meaning\nof the accreditation standard,\n(2) Section 65(2)(e)—\nomit, insert—\n(e) the date of expiry of the prescribed\naccreditation of the licensed provider;\n26 Amendment of s 111 (Power to require information)\n(1) Section 111—\ninsert—\n(1A) This section also applies if an inspector\nreasonably believes—\n(a) a person may be able to give information\n(compliance information) about a licensed\nprovider's compliance with this Act; and\n1\n2\n3\n4\nClause 5\n6\n7\n8\n9\nClause 10\n11\n12\n13\n14\n15\n16\n17\n18\nClause 19\n20\n21\n22\n23\n24\n25\n26","sortOrder":1},{"sectionNumber":"retrieval-0003","sectionType":"document_chunk","heading":"Document excerpt 3","content":"[s 27]\nHealth Legislation Amendment Bill (No. 3) 2025\nPart 2 Amendment of Assisted Reproductive Technology Act 2024\nPage 23\nAuthorised by the Parliamentary Counsel\n(b) the compliance information is necessary for\nthe inspector to perform the inspector’s\nfunction mentioned in section 69(a).\n(2) Section 111(2)(a)—\nomit, insert—\n(a) either—\n(i) information related to the offence\nmentioned in subsection (1); or\n(ii) the compliance information mentioned\nin subsection (2)(a); or\n(3) Section 111(2)(b), ‘paragraph (a)’—\nomit, insert—\nparagraph (a)(i) or (ii)\n(4) Section 111(1A) to (3)—\nrenumber as section 111(2) to (4).\n27 Amendment of s 112 (Offence to contravene information\nrequirement)\nSection 112(1), ‘section 111(2)’—\nomit, insert—\nsection 111(3)\n28 Amendment of s 119 (Definitions for part)\n(1) Section 119—\ninsert—\npart 2 decision means—\n(a) a decision to refuse to approve an\napplication for approval to use a gamete or\nembryo under section 39B(2) or 39C(2); or\n1\n2\n3\n4\n5\n6\n7\n8\n9\n10\n11\n12\n13\n14\n15\nClause 16\n17\n18\n19\n20\nClause 21\n22\n23\n24\n25\n26\n27\n\n[s 29]\nHealth Legislation Amendment Bill (No. 3) 2025\nPart 2 Amendment of Assisted Reproductive Technology Act 2024\nPage 24\nAuthorised by the Parliamentary Counsel\n(b) a decision to refuse to approve an\napplication for approval to destroy a record\nunder section 37(3).\n(2) Section 119, definition reviewable decision, before paragraph\n(a)—\ninsert—\n(aa) a part 2 decision;\n(3) Section 119, definition reviewable decision, paragraphs (aa)\nto (e)—\nrenumber as paragraphs (a) to (f).\n29 Replacement of s 120 (Review process must start with\ninternal review)\nSection 120—\nomit, insert—\n120 Review process for reviewable decisions\n(1) For a reviewable decision that is a part 2 decision,\nreview under this part is internal review under\ndivision 2 only.\n(2) For any other reviewable decision, review under\nthis part is—\n(a) internal review under division 2; and\n(b) if a decision on an application for internal\nreview of the reviewable decision has been\nmade, or is taken to have been made, under\ndivision 2—external review by QCAT under\ndivision 4.\n30 Amendment of s 123 (Internal review)\n(1) Section 123(1)(a) to (c)—\nomit, insert—\n1\n2\n3\n4\n5\n6\n7\n8\n9\n10\nClause 11\n12\n13\n14\n15\n16\n17\n18\n19\n20\n21\n22\n23\n24\n25\n26\nClause 27\n28\n29\n\n[s 31]\nHealth Legislation Amendment Bill (No. 3) 2025\nPart 2 Amendment of Assisted Reproductive Technology Act 2024\nPage 25\nAuthorised by the Parliamentary Counsel\n(a) review the reviewable decision; and\n(b) decide to—\n(i) confirm the reviewable decision; or\n(ii) amend the reviewable decision; or\n(iii) substitute another decision for the\nreviewable decision; and\n(c) give the affected person for the reviewable\ndecision—\n(i) if the reviewable decision is a part 2\ndecision—notice of the chief\nexecutive’s decision under paragraph\n(b); or\n(ii) otherwise—a QCAT information\nnotice for the chief executive’s decision\nunder paragraph (b).\n(2) Section 123(3), (4) and (5), ‘original’—\nomit.\n31 Amendment of s 124 (QCAT may stay operation of\nreviewable decision)\n(1) Section 124(1)—\nomit, insert—\n(1) This section applies in relation to a reviewable\ndecision, other than a part 2 decision.\n(1A) An affected person for the reviewable decision\nmay apply to QCAT, as provided under the\nQCAT Act, for a stay of the operation of the\ndecision.\n(2) Section 124(1A) to (5)—\nrenumber as section 124(2) to (6).\n1\n2\n3\n4\n5\n6\n7\n8\n9\n10\n11\n12\n13\n14\n15\n16\n17\nClause 18\n19\n20\n21\n22\n23\n24\n25\n26\n27\n28\n29\n\n[s 32]\nHealth Legislation Amendment Bill (No. 3) 2025\nPart 2 Amendment of Assisted Reproductive Technology Act 2024\nPage 26\nAuthorised by the Parliamentary Counsel\n32 Replacement of s 125 (Applying for QCAT external\nreview)\nSection 125—\nomit, insert—\n125 Applying for QCAT external review\n(1) This section applies if an affected person for a\nreviewable decision is required to be given a\nQCAT information notice under section\n123(1)(c)(ii) for an internal review decision.\n(2) The affected person may apply to QCAT, as\nprovided under the QCAT Act, for a review of the\ninternal review decision.\nNote—\nSection 56 also provides for a QCAT external review of\ncertain decisions of the registrar under part 3.\n33 Amendment of s 138 (Executive officer may be taken to\nhave committed offence against deemed executive\nliability provision)\nSection 138(4), definition deemed executive liability\nprovision, paragraph (c), ‘section 139(2)’—\nomit, insert—\nsection 139(1)\n34 Insertion of new pt 9, div 1, hdg\nBefore section 144—\ninsert—\nDivision 1 Transitional provisions\ncommencing on 19\nSeptember 2024\nClause 1\n2\n3\n4\n5\n6\n7\n8\n9\n10\n11\n12\n13\n14\n15\nClause 16\n17\n18\n19\n20\n21\n22\nClause 23\n24\n25\n26\n27\n28\n\n[s 35]\nHealth Legislation Amendment Bill (No. 3) 2025\nPart 2 Amendment of Assisted Reproductive Technology Act 2024\nPage 27\nAuthorised by the Parliamentary Counsel\n35 Insertion of new pt 9, div 2, hdg\nAfter section 144—\ninsert—\nDivision 2 Other transitional\nprovisions for Act No. 46 of\n2024\n36 Insertion of new pt 9, div 2, sdiv 1\nBefore section 145—\ninsert—\nSubdivision 1 Preliminary\n144B Definitions for division\nIn this division—\nfuture ART procedure, for a person mentioned in\nnew section 146(1)(a)(i) or 147(1)(a), means an\nART procedure carried out after the\ncommencement of this section for any of the\nfollowing persons—\n(a) the person;\n(b) a person who, at the relevant time, was the\nperson’s spouse;\n(c) a surrogate of the person;\n(d) a surrogate of a person who, at the relevant\ntime, was the person’s spouse.\nnew, in relation to a provision of this Act, means\nthe provision as in force from the commencement.\nrelevant time see section 144C(3).\nClause 1\n2\n3\n4\n5\n6\nClause 7\n8\n9\n10\n11\n12\n13\n14\n15\n16\n17\n18\n19\n20\n21\n22\n23\n24\n25\n26\n\n[s 37]\nHealth Legislation Amendment Bill (No. 3) 2025\nPart 2 Amendment of Assisted Reproductive Technology Act 2024\nPage 28\nAuthorised by the Parliamentary Counsel\n144C Particular references to spouses\n(1) This section applies in relation to a person\nmentioned in new section 146(1)(a)(i) or\n147(1)(a) if, at the relevant time, the person and\nthe person’s spouse were separated and were\nliving separately and apart.\n(2) For this division, the spouse is taken not to have\nbeen a spouse of the person at the relevant time.\n(3) For subsection (1), the relevant time is—\n(a) for a person mentioned in new section\n146(1)(a)(i)—the time when an ART\nprovider allocated donated gametes for use\nby the person in ART procedures as\nmentioned in that section; or\n(b) for a person mentioned in new section\n147(1)(a)—the time when an ART provider\nallocated a donated embryo for use by the\nperson in ART procedures as mentioned in\nthat section.\n37 Insertion of new pt 9, div 2, sdiv 2, hdg\nAfter section 144C, as inserted by this Act—\ninsert—\nSubdivision 2 Licensing\n38 Amendment of s 145 (Licensing of existing ART\nproviders)\nSection 145(2)—\nomit, insert—\n(2) Subsection (3) applies to an ART provider if—\n(a) the ART provider provided ART services\nimmediately before the commencement of\nsection 12; and\n1\n2\n3\n4\n5\n6\n7\n8\n9\n10\n11\n12\n13\n14\n15\n16\n17\n18\n19\nClause 20\n21\n22\n23\nClause 24\n25\n26\n27\n28\n29\n30\n31\n\n[s 39]\nHealth Legislation Amendment Bill (No. 3) 2025\nPart 2 Amendment of Assisted Reproductive Technology Act 2024\nPage 29\nAuthorised by the Parliamentary Counsel\n(b) the ART provider has prescribed\naccreditation during the initial licensing\nassessment period.\n(3) During the initial licensing assessment period, the\nART provider is taken to be a licensed provider\nfor sections 12, 61, 77 and 145A.\n39 Insertion of new s 145A\nAfter section 145—\ninsert—\n145A Licensed providers’ notification of particular\nevents that happened before\ncommencement—new s 61\n(1) This section applies in relation to a licensed\nprovider if—\n(a) an event happened before the\ncommencement of new section 61; and\n(b) the event would have been a serious adverse\nevent for the licensed provider had new\nsection 61 been in force when the event\nhappened; and\n(c) the licensed provider becomes aware of the\nevent after the commencement of new\nsection 61.\n(2) New section 61 applies as if the event were a\nserious adverse event within the meaning of that\nsection.\n40 Insertion of new pt 9, div 2, sdiv 3\nAfter section 145A, as inserted by this Act—\ninsert—\nSubdivision 3 Provisions for general\noperation of part 2\n1\n2\n3\n4\n5\n6\nClause 7\n8\n9\n10\n11\n12\n13\n14\n15\n16\n17\n18\n19\n20\n21\n22\n23\n24\n25\n26\nClause 27\n28\n29\n30\n31\n\n[s 40]\nHealth Legislation Amendment Bill (No. 3) 2025\nPart 2 Amendment of Assisted Reproductive Technology Act 2024\nPage 30\nAuthorised by the Parliamentary Counsel\n145B Donor-related Australian families—new s 25\nFor working out the number of donor-related\nAustralian families for new section 25, it does not\nmatter whether a person or a child mentioned in\nthat section was born before or after the\ncommencement of this section.\n145C Time limits on use of existing donated\ngametes and embryos—new s 27\n(1) Subject to new sections 146 to 148, new section\n27 applies in relation to the use of a donated\ngamete or donated embryo in an ART procedure\ncarried out after the commencement of this\nsection.\n(2) Subsection (1) applies—\n(a) whether or not the donated gamete was\nobtained, or the donated embryo was\ncreated, before the commencement of this\nsection; and\n(b) even if the period mentioned in new section\n27(1) during which the donated gamete or\ndonated embryo may be used in an ART\nprocedure ended before the commencement\nof this section.\n145D Record-keeping—s 36\n(1) Subsection (2) applies if, before 19 September\n2024, an ART provider collected information of a\ntype mentioned in a provision of part 2, division 6.\n(2) A reference in section 36 to information an ART\nprovider is required to collect under part 2,\ndivision 6 includes, and is taken to have always\nincluded, a reference to the information\nmentioned in subsection (1).\n1\n2\n3\n4\n5\n6\n7\n8\n9\n10\n11\n12\n13\n14\n15\n16\n17\n18\n19\n20\n21\n22\n23\n24\n25\n26\n27\n28\n29\n30\n31\n32\n\n[s 41]\nHealth Legislation Amendment Bill (No. 3) 2025\nPart 2 Amendment of Assisted Reproductive Technology Act 2024\nPage 31\nAuthorised by the Parliamentary Counsel\n145E Disclosure of health information—s 38\n(1) This section applies to a reference in section 38\nto—\n(a) a donor-conceived person born as a result of\nan ART procedure; or\n(b) a donor-conceived sibling of a person\nmentioned in paragraph (a).\n(2) The reference includes, and is taken to have\nalways included, a reference to a donor-conceived\nperson, or donor-conceived sibling, born as a\nresult of an ART procedure that was carried out\nbefore the commencement of section 38.\n41 Insertion of new pt 9, div 2, sdiv 4, hdg\nAfter section 145E, as inserted by this Act—\ninsert—\nSubdivision 4 Provisions about use of\nparticular gametes and\nembryos obtained before\n19 September 2024\n42 Replacement of ss 146–149\nSections 146 to 149—\nomit, insert—\n146 Donated gametes previously allocated to\nperson for ART procedures\n(1) This section applies if—\n(a) before 19 September 2024—\n(i) an ART provider allocated donated\ngametes for use by a person in ART\nprocedures; and\n1\n2\n3\n4\n5\n6\n7\n8\n9\n10\n11\n12\nClause 13\n14\n15\n16\n17\n18\n19\nClause 20\n21\n22\n23\n24\n25\n26\n27\n28\n29\n\n[s 42]\nHealth Legislation Amendment Bill (No. 3) 2025\nPart 2 Amendment of Assisted Reproductive Technology Act 2024\nPage 32\nAuthorised by the Parliamentary Counsel\n(ii) the person, or a surrogate of the person,\nbecame pregnant as a result of the use\nof some of those donated gametes in an\nART procedure; and\n(b) after the commencement of this section, an\nART provider proposes to use the remaining\ndonated gametes in future ART procedures\nfor the person.\n(2) The ART provider may use the remaining donated\ngametes in future ART procedures for the person\ndespite the donor’s consent to the use of the\nremaining gametes in an ART procedure—\n(a) not complying with a requirement for\nconsent mentioned in new section 18(2); or\n(b) not being in writing.\n(3) However, subsection (2) does not apply in\nrelation to the use of a gamete if—\n(a) the donor had previously consented to the\nuse of the gamete in an ART procedure; and\n(b) since giving the consent, the donor has—\n(i) withdrawn the consent under section\n20; or\n(ii) otherwise clearly communicated the\nwithdrawal of the consent to the ART\nprovider, whether or not in writing.\n(4) The following limitations under part 2 do not\napply to the use of the remaining donated gametes\nin future ART procedures for the person—\n(a) any limit on the period within which the\ngametes may be used;\n(b) any limit on the number of donor-related\nAustralian families who may use the\ngametes.\n(5) Also, new section 33(4) does not apply in relation\n1\n2\n3\n4\n5\n6\n7\n8\n9\n10\n11\n12\n13\n14\n15\n16\n17\n18\n19\n20\n21\n22\n23\n24\n25\n26\n27\n28\n29\n30\n31\n32\n33\n34\n\n[s 42]\nHealth Legislation Amendment Bill (No. 3) 2025\nPart 2 Amendment of Assisted Reproductive Technology Act 2024\nPage 33\nAuthorised by the Parliamentary Counsel\nto the use of the remaining donated gametes in\nfuture ART procedures for the person.\n147 Donated embryo previously allocated to a\nperson for ART procedures\n(1) This section applies if—\n(a) before 19 September 2024, an ART provider\nallocated a donated embryo for use by a\nperson in an ART procedure; and\n(b) after the commencement of this section, an\nART provider proposes to use the donated\nembryo in a future ART procedure for the\nperson.\n(2) The ART provider may use the donated embryo in\nthe future ART procedure for the person despite\nthe donor’s consent to the use of the embryo in an\nART procedure—\n(a) not complying with a requirement for\nconsent mentioned in new section 18(2); or\n(b) not being in writing.\n(3) However, subsection (2) does not apply in\nrelation to the use of the donated embryo if—\n(a) the donor had previously consented to the\nuse of the embryo in an ART procedure; and\n(b) since giving the consent, the donor has—\n(i) withdrawn the consent under section\n20; or\n(ii) otherwise clearly communicated the\nwithdrawal of the consent to the ART\nprovider, whether or not in writing.\n(4) The following limitations under part 2 do not\napply to the use of the donated embryo in the\nfuture ART procedure for the person—\n1\n2\n3\n4\n5\n6\n7\n8\n9\n10\n11\n12\n13\n14\n15\n16\n17\n18\n19\n20\n21\n22\n23\n24\n25\n26\n27\n28\n29\n30\n31\n32\n\n[s 42]\nHealth Legislation Amendment Bill (No. 3) 2025\nPart 2 Amendment of Assisted Reproductive Technology Act 2024\nPage 34\nAuthorised by the Parliamentary Counsel\n(a) any limit on the period within which the\nembryo may be used;\n(b) any limit on the number of donor-related\nAustralian families who may use the\nembryo.\n(5) Also, new section 33(4) does not apply in relation\nto the use of the donated embryo in the future\nART procedure for the person.\n148 Embryo created with donated gamete not yet\nused for ART procedure\n(1) This section applies if—\n(a) before 19 September 2024, an embryo was\ncreated with a donated gamete; and\n(b) after the commencement of this section, an\nART provider proposes to use the embryo in\nan ART procedure for a person.\n(2) The chief executive may, on application by the\nART provider, approve the use of the embryo in\nthe ART procedure for the person if satisfied there\nare reasonable grounds for using the embryo,\nhaving regard to the following matters—\n(a) when the embryo was created;\n(b) whether, when the embryo was created,\nthere was a reasonable expectation that it\nwould be used in an ART procedure for a\nperson;\n(c) any other relevant matter.\n(3) If an approval is given under subsection (2) to the\nART provider, the ART provider may use the\nembryo in the ART procedure despite—\n(a) new section 25, 27 or 33; or\n(b) the consent of the donor to the use of the\nembryo in an ART procedure—\n1\n2\n3\n4\n5\n6\n7\n8\n9\n10\n11\n12\n13\n14\n15\n16\n17\n18\n19\n20\n21\n22\n23\n24\n25\n26\n27\n28\n29\n30\n31\n32\n33\n\n[s 42]\nHealth Legislation Amendment Bill (No. 3) 2025\nPart 2 Amendment of Assisted Reproductive Technology Act 2024\nPage 35\nAuthorised by the Parliamentary Counsel\n(i) not complying with a requirement for\nconsent mentioned in new section\n18(2); or\n(ii) not being in writing.\n(4) However, subsection (3)(b) does not apply in\nrelation to the use of an embryo if—\n(a) the donor had previously consented to the\nuse of the embryo in an ART procedure; and\n(b) since giving the consent, the donor has—\n(i) withdrawn the consent under section\n20; or\n(ii) otherwise clearly communicated the\nwithdrawal of the consent to the ART\nprovider, whether or not in writing.\n(5) If the chief executive decides to refuse to give an\napproval under subsection (2), the chief executive\nmust, as soon as practicable after the decision is\nmade, give the applicant an information notice for\nthe decision.\n(6) A decision of the chief executive mentioned in\nsubsection (5) is taken to be a part 2 decision\nwithin the meaning of section 119.\n(7) New part 2, division 8 does not apply in relation\nto the use of the embryo in the ART procedure for\nthe person.\n149 Use of particular gametes obtained before 19\nSeptember 2024—collection of information\n(1) This section applies if—\n(a) an ART provider obtained a gamete before\n19 September 2024 for use in an ART\nprocedure or for storage for use in an ART\nprocedure; and\n1\n2\n3\n4\n5\n6\n7\n8\n9\n10\n11\n12\n13\n14\n15\n16\n17\n18\n19\n20\n21\n22\n23\n24\n25\n26\n27\n28\n29\n30\n31\n32","sortOrder":2},{"sectionNumber":"retrieval-0004","sectionType":"document_chunk","heading":"Document excerpt 4","content":"[s 43]\nHealth Legislation Amendment Bill (No. 3) 2025\nPart 2 Amendment of Assisted Reproductive Technology Act 2024\nPage 36\nAuthorised by the Parliamentary Counsel\n(b) immediately before the commencement of\nthis section, the gamete had not been used in\nan ART procedure; and\n(c) new sections 146 and 147 do not apply in\nrelation to the use of the gamete in an ART\nprocedure.\n(2) New section 33(4) does not prevent the use of the\ngamete, or an embryo created using the gamete, in\nan ART procedure if—\n(a) the ART provider collected the information\nmentioned in new section 33(1) in relation\nto the gamete before the gamete was\nobtained; or\n(b) the ART provider collects the information\nmentioned in new section 33(1) in relation\nto the gamete before the gamete or embryo\nis used in the ART procedure; or\n(c) the chief executive approves the use of the\ngamete or embryo in the ART procedure\nunder new section 39C.\n43 Renumbering and relocation of s 150 (Time within which\ninformation about pregnancies and births to be collected\nby ART providers)\nSection 150—\nrenumber as section 144A and relocate to part 9, division 1, as\nnumbered by this Act.\n44 Insertion of new pt 9, div 2, sdiv 5, hdg\nBefore section 151—\ninsert—\nSubdivision 5 Miscellaneous\n1\n2\n3\n4\n5\n6\n7\n8\n9\n10\n11\n12\n13\n14\n15\n16\n17\n18\n19\n20\nClause 21\n22\n23\n24\n25\n26\nClause 27\n28\n29\n30\n\n[s 45]\nHealth Legislation Amendment Bill (No. 3) 2025\nPart 2 Amendment of Assisted Reproductive Technology Act 2024\nPage 37\nAuthorised by the Parliamentary Counsel\n45 Insertion of new ss 152 and 153\nAfter section 151—\ninsert—\n152 Relationship of division with s 144\nTo the extent of any inconsistency between a\nprovision of this division and section 144(1)(a),\n(c) or (d), the provision of this division prevails.\n153 Transitional regulation-making power\n(1) A regulation (a transitional regulation) may\nmake provision about a matter for which this Act\ndoes not provide or sufficiently provide.\n(2) A transitional regulation may have retrospective\noperation to a day not earlier than the day this\nsection commences.\n(3) A transitional regulation must declare it is a\ntransitional regulation.\n(4) This section and any transitional regulation expire\non the day that is 2 years after the day this section\ncommences.\n46 Amendment of sch 1 (Dictionary)\n(1) Schedule 1, definition RTAC accreditation—\nomit.\n(2) Schedule 1—\ninsert—\naccreditation standard, for part 4, see section\n56A.\ndonor-related Australian families see section\n25(3).\npart 2 decision, for part 6, see section 119.\nClause 1\n2\n3\n4\n5\n6\n7\n8\n9\n10\n11\n12\n13\n14\n15\n16\n17\n18\n19\nClause 20\n21\n22\n23\n24\n25\n26\n27\n28\n29\n\n[s 47]\nHealth Legislation Amendment Bill (No. 3) 2025\nPart 3 Amendment of Health and Wellbeing Queensland Act 2019\nPage 38\nAuthorised by the Parliamentary Counsel\nprescribed accreditation, in relation to a person,\nmeans accreditation of the person, or of facilities\noperated by the person, by an entity prescribed by\nregulation.\n(3) Schedule 1, definition contact information—\nomit, insert—\ncontact information, for a person, means the\nperson’s residential address, phone number or\nemail address or any other way the person may be\ncontacted.\nPart 3 Amendment of Health and\nWellbeing Queensland Act 2019\n47 Act amended\nThis part amends the Health and Wellbeing Queensland Act\n2019.\n48 Amendment of s 23 (Vacancy in office)\n(1) Section 23(c), ‘becomes’—\nomit, insert—\nis\n(2) Section 23(d)—\nomit, insert—\n(d) is removed from office under subsection (2).\n(3) Section 23—\ninsert—\n(2) The Governor in Council may, at any time,\nremove a board member from office for any\nreason or none.\n1\n2\n3\n4\n5\n6\n7\n8\n9\n10\n11\n12\nClause 13\n14\n15\nClause 16\n17\n18\n19\n20\n21\n22\n23\n24\n25\n26\n27\n\n[s 49]\nHealth Legislation Amendment Bill (No. 3) 2025\nPart 3 Amendment of Health and Wellbeing Queensland Act 2019\nPage 39\nAuthorised by the Parliamentary Counsel\n49 Amendment of s 24 (Acting board member)\nSection 24(5), ‘section 25(1)(b)(iv)’—\nomit, insert—\nsection 25(1)(b)\n50 Amendment of s 37 (Vacancy in office)\n(1) Section 37(1)(c), ‘becomes’—\nomit, insert—\nis\n(2) Section 37(1)(d)—\nomit, insert—\n(d) is removed from office under subsection (3).\n(3) Section 37—\ninsert—\n(3) The Governor in Council may, at any time,\nremove the chief executive officer from office for\nany reason or none.\n51 Amendment of s 38 (Acting chief executive officer)\nSection 38(5), ‘section 25(1)(b)(iv) or (v)’—\nomit, insert—\nsection 25(1)(b)\n52 Insertion of new pt 7\nAfter part 6—\ninsert—\nClause 1\n2\n3\n4\nClause 5\n6\n7\n8\n9\n10\n11\n12\n13\n14\n15\n16\nClause 17\n18\n19\n20\nClause 21\n22\n23\n\n[s 53]\nHealth Legislation Amendment Bill (No. 3) 2025\nPart 4 Amendment of Health Legislation Amendment Act 2025\nPage 40\nAuthorised by the Parliamentary Counsel\nPart 7 Transitional provisions\nfor Health Legislation\nAmendment Act (No. 3)\n2025\n52 Vacancy in office of board member\nSection 23(2) applies to a board member whether\nthe member is appointed before or after the\ncommencement.\n53 Vacancy in office of chief executive officer\nSection 37(3) applies to the chief executive\nofficer whether the officer is appointed before or\nafter the commencement.\nPart 4 Amendment of Health\nLegislation Amendment Act\n2025\n53 Act amended\nThis part amends the Health Legislation Amendment Act\n2025.\n54 Replacement of s 7 (Amendment of s 28 (Removal from\noffice of board members))\nSection 7—\nomit, insert—\n7 Amendment of s 25A (Disqualification as\nboard member)\nSection 25A—\n1\n2\n3\n4\n5\n6\n7\n8\n9\n10\n11\n12\n13\n14\n15\nClause 16\n17\n18\nClause 19\n20\n21\n22\n23\n24\n25\n\n[s 55]\nHealth Legislation Amendment Bill (No. 3) 2025\nPart 5 Amendment of Hospital and Health Boards Act 2011\nPage 41\nAuthorised by the Parliamentary Counsel\ninsert—\n(d) was appointed because the person was a\nHHS clinician and has stopped being a HHS\nclinician.\nEditor’s note—\nLegislation ultimately amended—\n• Hospital and Health Boards Act 2011\nPart 5 Amendment of Hospital and\nHealth Boards Act 2011\n55 Act amended\nThis part amends the Hospital and Health Boards Act 2011.\n56 Insertion of new s 25A\nAfter section 25—\ninsert—\n25A Disqualification as board member\nA person is disqualified from becoming, or\ncontinuing as, a board member if the person—\n(a) is an insolvent under administration; or\n(b) is disqualified from managing corporations\nbecause of the Corporations Act, part 2D.6;\nor\n(c) has a conviction for an indictable offence or\nan offence against this Act.\n57 Amendment of s 27 (Vacation of office of board member)\n(1) Section 27(b)—\nomit, insert—\n1\n2\n3\n4\n5\n6\n7\n8\n9\nClause 10\n11\nClause 12\n13\n14\n15\n16\n17\n18\n19\n20\n21\n22\n23\nClause 24\n25\n26\n\n[s 58]\nHealth Legislation Amendment Bill (No. 3) 2025\nPart 5 Amendment of Hospital and Health Boards Act 2011\nPage 42\nAuthorised by the Parliamentary Counsel\n(b) completes a term of office and is not\nreappointed; or\n(c) is disqualified from continuing as a member\nunder section 25A; or\n(d) is removed from office under subsection (2).\n(2) Section 27—\ninsert—\n(2) The Governor in Council may, at any time,\nremove a board member from office for any\nreason or none.\n58 Amendment of s 27A (Suspension from office of Hospital\nand Health Board members)\n(1) Section 27A(1)(b)—\nomit.\n(2) Section 27A(1)(c)—\nrenumber as section 27A(1)(b).\n59 Omission of s 28 (Removal from office of board\nmembers)\nSection 28—\nomit.\n60 Insertion of new pt 13, div 9\nPart 13—\ninsert—\nDivision 9 Transitional provision for\nHealth Legislation\nAmendment Act (No. 3)\n2025\n1\n2\n3\n4\n5\n6\n7\n8\n9\n10\nClause 11\n12\n13\n14\n15\n16\nClause 17\n18\n19\n20\nClause 21\n22\n23\n24\n25\n26\n27\n\n[s 61]\nHealth Legislation Amendment Bill (No. 3) 2025\nPart 6 Amendment of Hospital Foundations Act 2018\nPage 43\nAuthorised by the Parliamentary Counsel\n332 Vacancy in office of board member\nSection 27(2) applies to a board member whether\nthe member is appointed before or after the\ncommencement.\n61 Amendment of sch 2 (Dictionary)\nSchedule 2—\ninsert—\nconviction means a finding of guilt or acceptance\nof a plea of guilty by a court, whether or not a\nconviction is recorded.\nPart 6 Amendment of Hospital\nFoundations Act 2018\n62 Act amended\nThis part amends the Hospital Foundations Act 2018.\n63 Amendment of s 33 (Disqualification from becoming\nmember)\n(1) Section 33, heading, ‘from becoming member’—\nomit, insert—\nas member\n(2) Section 33, ‘becoming a member’—\nomit, insert—\nbecoming, or continuing as, a member\n(3) Section 33—\ninsert—\n(f) consents to the borrowing of an amount that\nthe foundation is not lawfully authorised to\n1\n2\n3\n4\nClause 5\n6\n7\n8\n9\n10\n11\n12\nClause 13\n14\nClause 15\n16\n17\n18\n19\n20\n21\n22\n23\n24\n25\n26\n\n[s 64]\nHealth Legislation Amendment Bill (No. 3) 2025\nPart 6 Amendment of Hospital Foundations Act 2018\nPage 44\nAuthorised by the Parliamentary Counsel\nborrow under the Statutory Bodies Financial\nArrangements Act 1982.\n64 Omission of s 34 (Removal from office)\nSection 34—\nomit.\n65 Amendment of s 35 (Vacancy in office)\n(1) Section 35(b)—\nomit, insert—\n(b) is disqualified from continuing as a member\nunder section 33; or\n(c) is removed from office under subsection (2).\n(2) Section 35—\ninsert—\n(2) The Governor in Council may, at any time,\nremove a board member from office for any\nreason or none.\n66 Insertion of new s 35A\nAfter section 35—\ninsert—\n35A Acting board member\n(1) This section applies if the office of a member is\nvacant.\n(2) The Minister may appoint a person to act in the\noffice for a period of not longer than 6 months.\n(3) However, the Minister may extend the\nappointment for a further period of not longer\nthan 6 months.\n1\n2\nClause 3\n4\n5\nClause 6\n7\n8\n9\n10\n11\n12\n13\n14\n15\n16\nClause 17\n18\n19\n20\n21\n22\n23\n24\n25\n26\n27\n\n[s 67]\nHealth Legislation Amendment Bill (No. 3) 2025\nPart 6 Amendment of Hospital Foundations Act 2018\nPage 45\nAuthorised by the Parliamentary Counsel\n(4) A person can not be appointed to act in the office\nunless the Minister could recommend the person\nfor appointment as a member under section 30.\n(5) This section does not limit the Governor in\nCouncil’s power under the Acts Interpretation Act\n1954, section 25(1)(b).\n67 Amendment of s 36 (Criminal history report)\nSection 36(1), from ‘person’—\nomit, insert—\nperson is disqualified from becoming or\ncontinuing as a member under section 33.\n68 Insertion of new pt 9, div 3\nPart 9—\ninsert—\nDivision 3 Transitional provision for\nHealth Legislation\nAmendment Act (No. 3)\n2025\n93 Vacancy in office of board member\nSection 35(2) applies to a board member whether\nthe member is appointed before or after the\ncommencement.\n1\n2\n3\n4\n5\n6\nClause 7\n8\n9\n10\n11\nClause 12\n13\n14\n15\n16\n17\n18\n19\n20\n21\n22\n\n[s 69]\nHealth Legislation Amendment Bill (No. 3) 2025\nPart 7 Amendment of Pharmacy Business Ownership Act 2024\nPage 46\nAuthorised by the Parliamentary Counsel\nPart 7 Amendment of Pharmacy\nBusiness Ownership Act 2024\n69 Act amended\nThis part amends the Pharmacy Business Ownership Act\n2024.\n70 Replacement of s 156 (Vacancy in office)\nSection 156—\nomit, insert—\n156 Vacancy in office\n(1) The office of a council member becomes vacant if\nthe member—\n(a) completes the member’s term of office and\nis not reappointed; or\n(b) is disqualified from continuing as a member\nunder section 151; or\n(c) resigns office as a council member under\nsection 155; or\n(d) is absent, other than as approved under\nsection 157, from 3 consecutive council\nmeetings of which at least 21 days notice\nhas been given; or\n(e) is removed from office under subsection (2).\n(2) The Governor in Council may, at any time,\nremove a council member from office for any\nreason or none.\n156A Acting council member\n(1) This section applies if the office of a council\nmember is vacant.\n1\n2\nClause 3\n4\n5\nClause 6\n7\n8\n9\n10\n11\n12\n13\n14\n15\n16\n17\n18\n19\n20\n21\n22\n23\n24\n25\n26\n27\n28\n\n[s 71]\nHealth Legislation Amendment Bill (No. 3) 2025\nPart 7 Amendment of Pharmacy Business Ownership Act 2024\nPage 47\nAuthorised by the Parliamentary Counsel\n(2) The Minister may appoint a person to act in the\noffice for a period of not longer than 6 months.\n(3) However, the Minister may extend the\nappointment for a further period of not longer\nthan 6 months.\n(4) A person can not be appointed to act in the office\nunless the Minister could recommend the person\nfor appointment as a council member under\nsection 150(3).\n(5) This section does not limit the Governor in\nCouncil’s power under the Acts Interpretation Act\n1954, section 25(1)(b).\n71 Amendment of s 171 (Vacancy in office)\n(1) Section 171(1)—\ninsert—\n(d) is removed from office under subsection (2).\n(2) Section 171—\ninsert—\n(2) The Governor in Council may, at any time,\nremove the chief executive officer from office for\nany reason or none.\n72 Amendment of s 172 (Acting chief executive officer)\nSection 172(5), ‘section 25(1)(b)(iv) or (v)’—\nomit, insert—\nsection 25(1)(b)\n73 Replacement of pt 14, hdg (Transitional provisions)\nPart 14, heading—\nomit, insert—\n1\n2\n3\n4\n5\n6\n7\n8\n9\n10\n11\n12\nClause 13\n14\n15\n16\n17\n18\n19\n20\n21\nClause 22\n23\n24\n25\nClause 26\n27\n28\n\n[s 74]\nHealth Legislation Amendment Bill (No. 3) 2025\nPart 7 Amendment of Pharmacy Business Ownership Act 2024\nPage 48\nAuthorised by the Parliamentary Counsel\nPart 14 Repeal and transitional\nprovisions for Act No. 9\nof 2024\n74 Relocation and renumbering of pt 15, div 1 (Repeal)\nPart 15, division 1—\nrelocate to part 14 and renumber as part 14, division 5.\n75 Replacement of pt 15 (Repeal and amendments of\nlegislation)\nPart 15—\nomit, insert—\nPart 15 Transitional provisions\nfor Health Legislation\nAmendment Act (No. 3)\n2025\n235 Vacancy in office of council member\nSection 156(2) applies to a council member\nwhether the member is appointed before or after\nthe commencement.\n236 Vacancy in office of chief executive officer\nSection 171(2) applies to the chief executive\nofficer whether the officer is appointed before or\nafter the commencement.\n1\n2\n3\nClause 4\n5\n6\nClause 7\n8\n9\n10\n11\n12\n13\n14\n15\n16\n17\n18\n19\n20\n21\n22\n\n[s 76]\nHealth Legislation Amendment Bill (No. 3) 2025\nPart 8 Amendment of Private Health Facilities Act 1999\nPage 49\nAuthorised by the Parliamentary Counsel\nPart 8 Amendment of Private Health\nFacilities Act 1999\n76 Act amended\nThis part amends the Private Health Facilities Act 1999.\n77 Amendment of s 48 (Conditions of licence)\nSection 48(1)(b) and (c)—\nomit, insert—\n(b) the licensee must comply with a standard of\naccreditation prescribed for a type of health\nservice, or all health services, provided at\nthe facility;\n(c) the licensee must comply with the standards\nmade under part 3 relevant to the facility;\n78 Amendment of s 50 (Term of licences)\nSection 50(2)—\nomit, insert—\n(2) The stated term must not exceed—\n(a) if the licence is being renewed under\ndivision 5—3 years; or\n(b) otherwise—1 year.\n79 Amendment of s 144 (Submission of reports)\nSection 144(2)(b)—\nomit, insert—\n(b) to enable the State to give information to a\ngovernment entity in the circumstances\nmentioned in section 147(4)(c);\n1\n2\nClause 3\n4\nClause 5\n6\n7\n8\n9\n10\n11\n12\n13\nClause 14\n15\n16\n17\n18\n19\n20\nClause 21\n22\n23\n24\n25\n26\n\n[s 80]\nHealth Legislation Amendment Bill (No. 3) 2025\nPart 9 Amendment of Transplantation and Anatomy Act 1979\nPage 50\nAuthorised by the Parliamentary Counsel\n80 Amendment of s 147 (Confidentiality of information)\n(1) Section 147(4)(c)(i)—\nomit, insert—\n(i) the chief executive gives the information to\na government entity under an agreement\nwith the entity;\n(2) Section 147(7), ‘The Commonwealth, other State or entity’—\nomit, insert—\nA government entity\n(3) Section 147(11)—\ninsert—\nagreement includes arrangement.\ngovernment entity means—\n(a) the Commonwealth or another State; or\n(b) an entity of the Commonwealth or another\nState; or\n(c) an entity of the State.\nPart 9 Amendment of Transplantation\nand Anatomy Act 1979\n81 Act amended\nThis part amends the Transplantation and Anatomy Act 1979.\nNote—\nSee also the amendments in schedule 1.\n82 Amendment of s 4 (Interpretation)\nSection 4—\ninsert—\nClause 1\n2\n3\n4\n5\n6\n7\n8\n9\n10\n11\n12\n13\n14\n15\n16\n17\n18\n19\nClause 20\n21\n22\n23\nClause 24\n25\n26\n\n[s 83]\nHealth Legislation Amendment Bill (No. 3) 2025\nPart 9 Amendment of Transplantation and Anatomy Act 1979\nPage 51\nAuthorised by the Parliamentary Counsel\nante-mortem intervention, for part 3A, see\nsection 25A.\ntissue donation viability means the viability of\ntissue for transplanting from a person after death\nto the body of another living person.\n83 Replacement of pt 2, div 4, hdg (Blood transfusions)\nPart 2, division 4, heading—\nomit, insert—\nDivision 4 Removal of blood for\nparticular purposes\n84 Amendment of s 17 (Consents by adults to removal of\nblood)\nSection 17, before ‘or for any’—\ninsert—\n(c) for the purpose of determining tissue\ndonation viability;\n85 Amendment of s 18 (Consents to removal of blood from\nchildren)\n(1) Section 18, heading, after ‘children’—\ninsert—\nfor particular purposes\n(2) Section 18, ‘section 17’—\nomit, insert—\nsection 17, other than for the purpose of\ndetermining tissue donation viability,\n1\n2\n3\n4\n5\nClause 6\n7\n8\n9\n10\nClause 11\n12\n13\n14\n15\n16\nClause 17\n18\n19\n20\n21\n22\n23\n24\n25","sortOrder":3},{"sectionNumber":"retrieval-0005","sectionType":"document_chunk","heading":"Document excerpt 5","content":"[s 86]\nHealth Legislation Amendment Bill (No. 3) 2025\nPart 9 Amendment of Transplantation and Anatomy Act 1979\nPage 52\nAuthorised by the Parliamentary Counsel\n86 Insertion of new s 18A\nAfter section 18—\ninsert—\n18A Consents to removal of blood from children or\nadults with impaired capacity for determining\ntissue donation viability\n(1) This section applies in relation to a person who\nis—\n(a) a child; or\n(b) an adult who does not have capacity to\nconsent to the removal of blood from the\nperson’s body.\n(2) The senior available next of kin of the person may\nconsent in writing to the removal of blood from\nthe body of the person for the purpose of\ndetermining tissue donation viability.\n87 Replacement of s 19 (Consent to be sufficient authority\nfor removal of blood)\nSection 19—\nomit, insert—\n19 Consent to be sufficient authority for removal\nof blood\nA consent given by or for a person under this\ndivision is sufficient authority for the removal of\nblood from the body of the person.\n88 Insertion of new pt 3A\nAfter section 25—\ninsert—\nPart 3A Ante-mortem\ninterventions\nClause 1\n2\n3\n4\n5\n6\n7\n8\n9\n10\n11\n12\n13\n14\n15\n16\nClause 17\n18\n19\n20\n21\n22\n23\n24\n25\nClause 26\n27\n28\n29\n30\n\n[s 88]\nHealth Legislation Amendment Bill (No. 3) 2025\nPart 9 Amendment of Transplantation and Anatomy Act 1979\nPage 53\nAuthorised by the Parliamentary Counsel\n25A What is an ante-mortem intervention\n(1) An ante-mortem intervention is a medical\nprocedure that is carried out on a living person to\ndetermine, maintain or improve the viability of\ntissue for transplanting, after the person’s death,\nto the body of another living person.\n(2) However, removing blood from the body of a\nliving person for the purpose of determining\ntissue donation viability is not an ante-mortem\nintervention.\nNote—\nSee section 18A in relation to removing blood for\ndetermining tissue donation viability.\n25B Authority for ante-mortem intervention—adult\nwith capacity\n(1) A person who is an adult may consent to the\ncarrying out of an ante-mortem intervention on\nthe person.\n(2) A consent under subsection (1) is sufficient\nauthority to carry out the ante-mortem\nintervention on the person.\n25C Authority for ante-mortem intervention—child\nor adult with impaired capacity\n(1) This section applies if—\n(a) a person is in a hospital; and\n(b) the person is—\n(i) a child; or\n(ii) an adult who does not have capacity to\nconsent to the carrying out of an\nante-mortem intervention on the\nperson; and\n1\n2\n3\n4\n5\n6\n7\n8\n9\n10\n11\n12\n13\n14\n15\n16\n17\n18\n19\n20\n21\n22\n23\n24\n25\n26\n27\n28\n29\n30\n31\n\n[s 88]\nHealth Legislation Amendment Bill (No. 3) 2025\nPart 9 Amendment of Transplantation and Anatomy Act 1979\nPage 54\nAuthorised by the Parliamentary Counsel\n(c) a decision or direction has been lawfully\nmade to withhold or withdraw\nlife-sustaining measures for the person; and\nNote—\nSee the Guardianship and Administration Act\n2000 and the Powers of Attorney Act 1998 in\nrelation to withholding or withdrawing\nlife-sustaining measures for an adult who has\nimpaired capacity.\n(d) before the withholding or withdrawal of\nlife-sustaining measures, a decision or\ndirection mentioned in paragraph (c) has not\nbeen revoked.\n(2) A designated officer may, in writing, authorise the\ncarrying out of an ante-mortem intervention on\nthe person if—\n(a) the senior available next of kin of the person\ngives written consent for the carrying out of\nthe ante-mortem intervention; and\n(b) the consent is not revoked before the\nante-mortem intervention is carried out.\n(3) However, if it is not practicable for the consent to\nbe given in writing, it may be given orally.\n(4) If the consent is given orally under subsection (3),\nthe designated officer must ensure that, as soon as\npracticable—\n(a) the fact of the giving of the consent and the\ndetails of the consent are reduced to writing\nand placed on the person’s hospital records;\nand\n(b) reasonable attempts are made to have the\nconsent confirmed in writing by the senior\navailable next of kin.\n(5) The designated officer must ensure that a written\nconsent obtained under subsection (2)(a) or (4)(b)\nis placed on the person’s hospital records as soon\n1\n2\n3\n4\n5\n6\n7\n8\n9\n10\n11\n12\n13\n14\n15\n16\n17\n18\n19\n20\n21\n22\n23\n24\n25\n26\n27\n28\n29\n30\n31\n32\n33\n34\n35\n36\n\nPage 55\nAuthorised by the Parliamentary Counsel\n[s 89]\nHealth Legislation Amendment Bill (No. 3) 2025\nPart 10 Other amendments\nas practicable.\n(6) An authority under subsection (2) is sufficient\nauthority to carry out the ante-mortem\nintervention on the person.\nPart 10 Other amendments\n89 Legislation amended\nSchedule 1 amends the legislation it mentions.\n1\n2\n3\n4\n5\nClause 6\n7\n\nSchedule 1\nHealth Legislation Amendment Bill (No. 3) 2025\nPage 56\nAuthorised by the Parliamentary Counsel\nSchedule 1 Other amendments\nsection 89\nPublic Health Act 2005\n1 Section 279AA, definition Commonwealth chief medical\nofficer—\nomit.\n2 Section 279AA—\ninsert—\nrelevant Commonwealth officer means the\nperson to whom notifications must be made under\nthe Commonwealth Act, section 14(1).\n3 Section 279AB, heading, ‘Commonwealth chief\nmedical’—\nomit, insert—\nrelevant Commonwealth\n4 Section 279AB(2), ‘Commonwealth chief medical’—\nomit, insert—\nrelevant Commonwealth\n5 Section 279AC(1)(a)(i), ‘Commonwealth chief medical’—\nomit, insert—\nrelevant Commonwealth\n1\n2\n3\n4\n5\n6\n7\n8\n9\n10\n11\n12\n13\n14\n15\n16\n17\n18\n19\n20\n21\n\nSchedule 1\nHealth Legislation Amendment Bill (No. 3) 2025\nPage 57\nAuthorised by the Parliamentary Counsel\n6 Schedule 2, definition Commonwealth chief medical\nofficer—\nomit.\n7 Schedule 2—\ninsert—\nrelevant Commonwealth officer, for chapter 6,\npart 3A, division 1, see section 279AA.\nTransplantation and Anatomy Act 1979\n1 Section 9, heading, ‘Blood transfusions’—\nomit, insert—\nParticular blood removal\n2 Section 12A, heading, from ‘Blood’ to ‘research’—\nomit, insert—\nParticular blood removal and donations\n© State of Queensland 2025\n1\n2\n3\n4\n5\n6\n7\n8\n9\n10\n11\n12\n13\n14","sortOrder":4}],"analysis":{"summary":{"status_summary":"The Bill received royal assent on a date not specified in the materials and most provisions commence immediately after the corresponding sections of the Assisted Reproductive Technology Act 2024 commence, with sections 77 and 78 to be proclaimed.","complexity_score":7,"likely_questions":["When will sections 77 and 78 (private health facility licence changes) commence?","Can the chief executive's refusal to approve use of a gamete be appealed externally?","What are the new disqualification grounds for hospital board members?","How does the Bill affect existing donated gametes that were allocated before 19 September 2024?","What is an ante-mortem intervention and who can authorise it?"],"complexity_factors":["Amends nine separate Acts, each with distinct regulatory schemes","Introduces new chief executive discretionary approval powers with subjective criteria","Contains complex transitional provisions for gametes and embryos obtained before September 2024","Changes both substantive ART rules and governance removal powers across multiple entities","Creates new legal concepts such as ante-mortem intervention and tissue donation viability"],"plain_english_summary":"This Bill amends nine Queensland Acts, chiefly tightening assisted reproductive technology (ART) rules—requiring gamete-provider consent, refining counselling, and giving the chief executive power to approve exceptions to donor/time limits or missing information (with only internal review). It also grandfathered some pre‑existing gametes/embryos.\n\nIt expands executive control over health boards (removal powers, new disqualifications, acting appointments), changes private‑facility accreditation and licence terms, and authorises ante‑mortem interventions and limited blood removal for transplant viability with next‑of‑kin consent. Most provisions have begun or await proclamation."},"flash_summary":{"complexity_score":9,"scope_assessment":{"changed":true,"description":"This Bill materially expands administrative discretion and the operational scope of the Assisted Reproductive Technology Act 2024 and several other health statutes. Key scope changes include: (1) empowering the chief executive to authorise exceptional uses of gametes and embryos that would otherwise be barred by statutory limits (ss 39A–39C), thereby shifting outcomes from automatic statutory limits to case-by-case administrative decisions; (2) restricting external review for those \"part 2\" decisions to internal review only (ss 119, 120), reducing independent external oversight; (3) inserting broad transitional carve-outs and retrospective regulation-making powers for older stored material (ss 145B–149, 153); (4) expanding executive removal powers and introducing acting-appointment rules across multiple health governance Acts (various sections in Parts 3–7), which alter governance structures beyond narrow technical amendments; and (5) adding new consent and process pathways for ante-mortem interventions and tissue-donation viability assessments (Transplantation and Anatomy Act new Part 3A and s 18A). These measures go beyond technical or clarifying amendments and change who decides, the available remedies, and the administrative architecture for assisted reproduction and organ/tissue donation."},"complexity_factors":["Amends 9 principal Acts (Assisted Reproductive Technology Act 2024; Health and Wellbeing Queensland Act 2019; Health Legislation Amendment Act 2025; Hospital and Health Boards Act 2011; Hospital Foundations Act 2018; Pharmacy Business Ownership Act 2024; Private Health Facilities Act 1999; Transplantation and Anatomy Act 1979; Public Health Act 2005) and Schedule changes—wide cross-legislation scope.","Numerous insertions of new sections and divisions (notably new Division 8 in ART Act, new Part 3A in Transplantation Act and extensive Part 9 transitional subdivisions) creating many cross-references.","Delegation of definitional detail to an \"accreditation standard\" approved by regulation (s 56A), shifting substantive rules out of the statute—adds complexity because the standard is external to the Act.","Layered review regime: creation of 'part 2 decisions' that are subject to internal review only (ss 119, 120) while other decisions remain subject to external QCAT review—adds conditional procedural complexity.","Multiple transitional provisions including retrospective regulation-making power (s 153) and detailed transitional rules for material obtained before 19 September 2024 (ss 145B–149)—creates temporal complexity.","New administrative discretion standards requiring balancing tests (\"reasonable grounds\", \"unfairly harsh\") in chief-executive approvals (ss 39B–39C) — introduces case-specific, fact-dependent decision-making.","Expanded record-keeping and notification obligations (ss 33, 36, 61) with new categories of required records (attempted-consent records, consent withdrawals) — operational complexity for providers.","Governance changes across multiple bodies (expanded removal powers, acting appointments, tightened disqualification criteria) mean the same themes recur across statutes but with slightly different drafting—replicated complexity.","Interplay between consent rules (s 16A), donor limits (s 25), time-limits (s 27), and approval/disposal procedures (ss 37, 39B) produces nested conditional logic and exceptions to exceptions.","New medical-practice rules (ante-mortem interventions ss 25A–25C) intersect with existing guardianship and life-sustaining-measures law creating cross-act dependencies and practical implementation questions."],"plain_english_summary":"**What this Bill does (mechanics)\n\n- Changes to assisted reproduction (Assisted Reproductive Technology Act 2024):\n  - Requires a gamete provider's consent before a gamete can be obtained or an attempt made (new s 16A). The consent of a child requires parent/guardian consent (s 16A).\n  - Creates a power for the chief executive to approve the use of particular donated gametes or embryos despite existing limits (new Division 8: ss 39A–39C). That power can override: the 10-family donor limit (s 25), time limits on using gametes/embryos (s 27), and some information-collection requirements (s 33). The chief executive must be satisfied of consent or reasonable steps to contact the donor and that there are reasonable grounds and that giving or refusing approval would not be unfairly harsh (s 39B–39C).\n  - Tightens and clarifies consent rules for donated material and adds record-keeping and notification obligations: more detailed contact information, required records of attempted-consent and consent withdrawals, and rules about destruction of records (ss 33, 36, 37). If the chief executive refuses approval to use a donated gamete/embryo, providers must dispose of it within 90 days after internal-review steps (s 27(2)-(3)).\n  - Limits external review (QCAT) for decisions in the new Part 2: certain chief-executive \"part 2\" decisions (approvals/refusals under ss 39B/39C and refusal to approve destruction of records under s 37) are subject only to internal review (ss 119, 120, 123). Other reviewable decisions still may proceed to external review if internal review has been completed (ss 120, 125).\n  - Introduces an \"accreditation standard\" (s 56A) to be approved by regulation and makes accreditation matters and certain personnel and events be defined by that standard rather than fixed in the Act (ss 56A, 57, 61, 64, 65).\n  - Adds transitional rules for use of gametes/embryos obtained before 19 September 2024, including carve-outs that allow previously allocated donated gametes/embryos to be used for the same persons despite new consent or limit requirements (ss 145B–149).\n\n- Governance and administrative changes across health laws:\n  - Expands executive removal powers: the Governor in Council may remove board members and chief executives from multiple bodies at any time, for any reason or none (Health and Wellbeing Queensland Act s 23(2) & s 37(3); Hospital and Health Boards Act ss 27(2); Hospital Foundations Act s 35(2); Pharmacy Business Ownership Act s 156(2), s 171(2)).\n  - Introduces acting-member/acting-officer appointment powers (hospital foundations, pharmacy council) with 6-month initial limits and one 6-month extension (Hospital Foundations Act s 35A; Pharmacy Business Ownership Act s 156A).\n  - Tightens disqualification rules for board/council membership (criminal convictions, insolvency, unlawful borrowings) and updates definitions (Hospital and Health Boards Act s 25A; Hospital Foundations Act s 33 changes).\n\n- Transplantation and tissue-donation changes:\n  - Clarifies consent rules for removal of blood for assessing tissue donation viability and permits next-of-kin (senior available next of kin) to consent for children or adults without capacity (s 18A).\n  - Creates a new Part for \"ante-mortem interventions\": defined as procedures on a living person intended to preserve tissue viability for transplant after death. Adults with capacity may consent; for children or adults without capacity in hospital where life-sustaining measures are being withdrawn, a designated officer may authorise the procedure if the senior available next of kin gives written (or in urgent cases oral) consent (new ss 25A–25C).\n\n- Other operational changes:\n  - Changes to private health facility licence terms and accreditation references, submission and confidentiality rules, and public register details (Private Health Facilities Act and Assisted Reproductive Technology Act amendments).\n  - Alters certain public health notification terminology (Schedule 1) and other technical tidy-ups.\n\nWho is affected\n\n- ART providers and clinics: additional record-keeping, notification obligations, potential disposal obligations, and a new application route to seek chief-executive approvals to use particular gametes/embryos (ss 36, 37, 39B, 39C, 27).\n- Gamete providers/donors and donor-conceived persons: consent rules clarified/expanded (s 16A), information collection and register entries changed (ss 33, 44), and transitional arrangements affecting older stored material (ss 145B–149).\n- The chief executive (Department): gains discretion to approve exceptional uses of gametes/embryos (ss 39B–39C), must decide internal reviews of those decisions (ss 120, 123), and to process record-destruction approvals (s 37).\n- Hospital staff, patients and next-of-kin: new process for ante-mortem interventions and next-of-kin consent pathways where capacity is lacking (ss 18A, 25A–25C).\n- Boards, councils and executive officers across health agencies: wider removal powers by the Governor in Council and tightened disqualification rules (multiple sections as above).\n\nWhy it matters (official rationale and practical trade-offs)\n\n- The Bill authorises administrative discretion to allow particular uses of gametes or embryos that would otherwise be prohibited by numerical caps, time limits or incomplete donor records (ss 39A–39C). The stated purpose is to provide flexibility in special cases; practically, that transfers decision-making power from prescriptive limits in the Act to an individualised administrative exercise.\n\n- Key trade-offs and implementation considerations:\n  - Concentration of decision power: the chief executive’s approval power (ss 39B–39C) substitutes a case-by-case administrative test for automatic statutory limits. That reduces bright-line predictability and increases reliance on the chief executive’s judgment about consent or \"reasonable grounds\" and whether refusal would be \"unfairly harsh\" (s 39B(2)(b)). Implementation costs include staffing, guidance and record systems to process applications and appeals.\n  - Reduced external oversight for these decisions: part 2 decisions are limited to internal review only (s 120(1)), so affected persons cannot proceed to QCAT for external review of those specific refusals. That changes the review landscape and concentrates dispute-resolution inside the agency (ss 119–125). The trade-off is faster administrative finality versus less independent external judicial oversight.\n  - Compliance and administrative burden on providers: additional data fields, keeping records of attempted-consent, notifications of certain events and the possibility of disposal within fixed timeframes after a refusal or internal-review confirmation increase operational and compliance costs for ART clinics (ss 33, 36, 61, 27(2)-(3)).\n  - Transitional complexity and retrospective regulation power: the Bill contains detailed transitional rules for material obtained before 19 September 2024 and authorises transitional regulations (s 153) that may operate retrospectively up to the commencement date. This raises implementation complexity for providers and regulators, and some legal uncertainty while transitional regulations are made (ss 145B–149, 153).\n  - Risks of uneven standards: shifting matters (such as what counts as a \"serious adverse event\" or which personnel must be named) out of the Act and into an accreditation standard approved by regulation (s 56A) creates a reliance on delegated instruments. That delegates substantial definitional work to regulation and to the accreditation document, increasing the importance of consultation and transparency when the standard is set (s 56A, and amendments referring to the accreditation standard in ss 57, 61, 64, 65).\n  - For tissue donation, the Bill creates a clear pathway for ante-mortem interventions and next-of-kin consent where capacity is lacking (ss 18A, 25A–25C). That introduces practical processes for hospitals but also requires safeguards in record-keeping and staff training (ss 25C(4)-(5)).\n\nWho pays, who decides, what behaviour changes (plain sentences)\n\n- ART providers pay in time and administrative costs: they must collect more information, keep new types of consent records (including attempted-consent records), notify serious events, and may need to dispose of material following specified decision stages (ss 33, 36, 61, 27).\n- The chief executive decides whether to approve exceptional uses of gametes/embryos and whether to approve destruction of records; the chief executive also handles internal review of those decisions (ss 39B–39C, 37, 120, 123).\n- The Governor in Council may remove board members and chief executives at any time (s 23(2); Hospital and Health Boards Act s 27(2), Hospital Foundations Act s 35(2), Pharmacy Act ss 156(2), 171(2)). That changes governance incentives for board members and executives.\n- Hospitals will change practice when considering ante-mortem interventions: designated officers may authorise these procedures following next-of-kin consent where the patient lacks capacity (ss 25B–25C).\n\nNet effect summary (mechanical, not a policy judgement)\n\n- The Bill moves a number of formerly prescriptive rules in assisted-reproduction laws into an administrative discretion framework (chief-executive approvals and accreditation standards) while increasing record-keeping and notification obligations for providers. It narrows external review for those administrative decisions, enlarges executive removal and acting-appointment powers in health governance, and creates statutory pathways for ante-mortem interventions and next-of-kin consents for tissue-donation assessment. These are concrete shifts in where and how decisions are made, who must bear compliance costs, and how disputes about those decisions are reviewed (see ss 16A, 33, 36, 37, 39A–39C, 120–125, 25A–25C)."}},"importantCases":[],"_links":{"self":"/api/acts/health-legislation-amendment-bill-no-3-2025","history":"/api/acts/health-legislation-amendment-bill-no-3-2025/history","analysis":"/api/acts/health-legislation-amendment-bill-no-3-2025/analysis","conflicts":"/api/acts/health-legislation-amendment-bill-no-3-2025/conflicts","importantCases":"/api/acts/health-legislation-amendment-bill-no-3-2025/important-cases","documents":"/api/acts/health-legislation-amendment-bill-no-3-2025/documents"}}